Reliable, Dose-Dependent Sedation Across Species: Xylaxin Injection delivers a predictable, titratable depth of sedation that veterinary practitioners can calibrate precisely to the clinical requirement, from mild tranquillisation for routine examination to deep sedation for surgical pre-anaesthesia. This dose-response reliability makes Xylaxin a versatile and trusted tool across the widest range of species and procedures in veterinary practice.

Safe and Fully Reversible with Specific Antidotes: One of the most clinically valuable attributes of Xylaxin is its full reversibility with established alpha-2 adrenergic antagonists including yohimbine hydrochloride, tolazoline, and atipamezole, allowing the veterinary practitioner to rapidly terminate sedation and restore the animal to consciousness when needed. This reversibility provides a significant safety advantage in clinical scenarios where prolonged sedation poses a physiological risk.

Effective Skeletal Muscle Relaxation for Stress-Free Handling: The centrally mediated muscle relaxant property of xylazine enables the safe and calm repositioning, examination, and surgical preparation of animals that would otherwise be impossible to handle safely. This benefits both the animal, by reducing the physiological stress response associated with forced restraint, and the attending practitioner, by providing a controlled and cooperative patient.

Broad-Spectrum Multi-Species Applicability: Xylaxin is one of the few injectable sedatives approved and clinically validated for use across companion animals, equines, large ruminants, camelids, and wildlife species, making it an indispensable single-vial solution for mixed-species veterinary practitioners, wildlife conservationists, and field veterinarians working across diverse animal populations.

Manufactured by India's Leading Veterinary Biologicals Company: Produced by Indian Immunologicals Limited, a WHO cGMP-certified, ISO 9001-compliant, NDDB-established pharmaceutical manufacturer with over four decades of uncompromised quality in veterinary and human biopharmaceutical production, Xylaxin carries the assurance of the highest manufacturing standards at every level of production.

How to Use:

Xylaxin Injection 30ml must be administered exclusively by a registered veterinary practitioner or under the direct supervision of a qualified veterinary professional. It is not to be self-administered or dispensed without a valid veterinary prescription. The preferred route of administration is intramuscular in most species. In horses, the preferred and recommended route is slow intravenous injection to minimise the risk of adverse cardiovascular effects. In dogs, intramuscular, subcutaneous, or intravenous administration may be employed depending on the clinical context and the degree of sedation required. In cats, intramuscular or subcutaneous administration is preferred. The dose volume and route must be calculated and determined by the attending veterinarian based on the species, body weight, health status, and intended clinical purpose of the procedure. Following administration, the animal should be kept in a quiet, calm environment and allowed to achieve the full depth of sedation undisturbed, as stimulation during the onset phase may result in unexpected movement or reactivity. Animals should not be left unmonitored during the period of sedation. If reversal is required, the specific antidote should be administered as directed by the veterinarian. Fasting of 6 to 24 hours prior to administration is advisable in dogs and cats where possible, to reduce the incidence of vomiting. For large animals and cattle, position the head to avoid regurgitation and aspiration risk. Do not administer to animals in advanced stages of pregnancy.

Storage Advice:

Store unopened Xylaxin Injection 30ml in a cool, dark, and dry place below 25 degrees Celsius, away from direct sunlight and sources of heat or humidity. Do not freeze. Once opened, the multi-dose vial should be kept sealed with its rubber stopper intact between uses, stored under refrigeration, and used within the recommended period as specified on the label. Handle all vials with appropriate aseptic technique to prevent contamination. Do not use after the best-before date printed on the vial label. Keep out of the reach of children. This product must be stored securely in a clinical or veterinary facility and must not be accessible to unauthorised individuals.

About the Brand:

Indian Immunologicals Limited (IIL) is a wholly owned subsidiary of the National Dairy Development Board (NDDB), established in 1982 in Hyderabad, India, with a foundational mission to make high-quality veterinary vaccines accessible and affordable to Indian farmers and animal health practitioners. Over four decades, IIL has grown into one of Asia's largest and most respected veterinary and human biologicals manufacturers, operating WHO cGMP-approved, ISO 9001-certified facilities and holding over 300 product registrations across more than 50 countries globally. IIL's research-driven philosophy, supported by a DSIR-approved R&D facility and a team of more than 60 scientists, underpins a portfolio of over 150 products spanning veterinary vaccines, human vaccines, injectable formulations, and nutraceuticals, all developed with an unwavering commitment to the One Health initiative. IIL's dedication to delivering safe, efficacious, and rigorously tested animal health solutions aligns with Animeal's commitment to offering only the most credible and clinically proven veterinary products to the practitioners and pet families we proudly serve. Discover Indian Immunologicals today.

Disclaimer:

Please note that Xylaxin Injection 30ml contains Xylazine Hydrochloride USP 20 mg/ml and is a prescription-only veterinary pharmaceutical. It may only be administered by or under the direct order and supervision of a licensed, registered veterinary practitioner. This product is not available for retail sale without a valid veterinary prescription and must not be self-administered under any circumstances. Xylaxin is not recommended for use in animals in the last trimester of pregnancy, as it may induce premature labour or fetal sedation. It should be used with extreme caution in animals with pre-existing cardiovascular disease, respiratory compromise, hepatic or renal impairment, severe debilitation, hypotension, or a history of seizure disorders. Xylazine is known to interact with epinephrine, barbiturates, certain narcotics, acepromazine, and prochlorperazine; the attending veterinarian must review concurrent medications before administration. For all animals receiving Xylaxin, appropriate resuscitative equipment, monitoring capability, and the relevant reversal agents including yohimbine hydrochloride, tolazoline, or atipamezole must be available at the point of administration. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.